Charles Awuzie Blames Global Health System Over Alexx Ekubo’s Reported Death
Public commentator and entrepreneur Charles Awuzie has reacted to reports of the death of Nollywood actor Alexx Ekubo, describing the development as a failure of global healthcare systems and calling for Africa to take greater control of medical innovation and disease treatment.
In a lengthy Facebook post following reports that the actor died after a battle with cancer, Awuzie lamented what he described as society’s inability to prevent deaths from terminal illnesses despite advances in science and technology.
Reflecting on the actor’s public image, Awuzie wrote: “He was tall, handsome — almost beautiful, intelligent and he had an extraordinary charisma that flowed with grace. He was charming — not only to women but even his fellow men acknowledged that he looked handsome.”
He said while many admired the actor’s appearance and success, cancer was allegedly “tearing him apart on the inside.”
Awuzie used the occasion to advocate for a shift from conventional healthcare funding to what he termed “longevity funding,” urging governments to establish agencies dedicated to extending human life and advancing preventive medicine.
“This is why I encourage Governments across the world to evolve from Funding Healthcare to Funding LONGEVITY,” he wrote. “Healthcare is reactive but a National Longevity Strategy is Proactive.”
The social commentator further argued that cancer deaths should no longer remain commonplace in modern society, insisting that humanity possesses the scientific capacity to significantly reduce mortality from such diseases.
“It’s 2026 and we are still losing humans to cancer,” he stated. “I hate death… I know death can be postponed. I know cancer can be cured.”
Awuzie also criticised the global pharmaceutical approval system, particularly the role of the United States Food and Drug Administration (FDA), claiming that several advanced cancer therapies remain inaccessible because of slow approval processes.
According to him, Africa should establish a continental drug regulatory agency capable of independently approving treatments and driving medical innovation on the continent.
“Africa must have its own version of FDA — at a continental level,” he said.
He cited emerging liver cancer therapies, including Lipid-Nanoparticle (LNP) gene therapies and bispecific antibodies, as examples of innovations that he believes deserve wider access.
Awuzie also challenged African scientists and biochemists to focus on developing local medical solutions rather than relying solely on foreign institutions.
“The world failed you. FDA failed you,” he wrote in tribute to the late actor.
“My name is Charles Awuzie and I call upon fellow African Biochemists and Scientists to start thinking SOLUTIONS and not employment.”
As of the time of filing this report, there has been no official confirmation from Alexx Ekubo’s family or representatives concerning reports of his death.
